Influence of formulation variables and manufacturing process on propranolol extended release profile from HPMC matrices tablets

Journal of Applied Polymer Science

Volumn 93, Issue 4, 2004, Pages 1886-1890

  Huang, Yaw Bin ^a   Tsai, Yi Hung ^a   Yang, Wan Chiech ^a   Chang, Jui Sheng ^a   Wu, Pao Chu ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Extended release; Gelation; Hydroxypropylmethylcellulose (hpmc); Propranolol; UV Vis spectroscopy; Viscosity

Indexed keywords

DIFFUSION; DISSOLUTION; DRUG PRODUCTS; GELATION; GRANULAR MATERIALS; HYDROGELS; HYDROPHILICITY; LUBRICANTS; POLYETHYLENE GLYCOLS; POROSITY; SURFACE ACTIVE AGENTS; ULTRAVIOLET SPECTROSCOPY; VISCOSITY;

EXTENDED RELEASES; HYDROXYPROPYLMETHYLCELLULOSE (HPMC); PROPRANOLOL; UV-VIS SPECTROSCOPY;

CELLULOSE;

POLYMER SCIENCE;

EID: 3142562736     PISSN: 00218995     EISSN: None     Source Type: Journal    
DOI: 10.1002/app.20655     Document Type: Article

References (25)

1. Rekhi, S. G.; Porter, S. C.; Jambhekar, S. S. Drug Dev Ind Pharm 1995, 221, 709.
2. Taylan, B.; Capan, Y.; Guven, O.; Kes, S.; Hincal, A. J Controlled Release 1996, 38, 11.
3. Eddington, N. D.; Ashraf, M.; Augsburger, L. L.; Leslie, J. L.; Fossler, M. J.; Lesko, L. J.; Shah, V. P.; Rekhi, G. S. Pharm Dev Tech 1998, 3, 535.
4. Gao, P.; Meury, R. H. J Pharm Sci 1996, 85, 725.
5. Gohel, M. C.; Amin, A. F. J Controlled Release 1998, 51, 115.
6. Huang, Y. B.; Tsai, Y. H.; Yang, W. C. Y. H.; Chang, J. S.; Wu, P. C. Eur J Pharm Biopharm, to appear.
7. Huang, Y. B.; Tsai, Y. H.; Yang, W. C. Y. H.; Chang, J. S.; Wu, P. C. Biol Pharm Bull to appear.
8. Cressman, W. A.; Summer, D. J Pharm Sci 1971, 60, 132.
9. Uchida, T.; Kawata, M.; Goto, S. J Pharmacobio-Dyn 1986, 9, 631.
10. Katori, N.; Okudaria, K.; Aoyagi, N.; Takeda, Y.; Uchiyama, M. J Pharmacobio-Dyn 1991, 14, 567.
11. Ford, J. L.; Rubinstein, M., II; IIogan, J. E. Int J Pharm 1985, 24, 339.
12. Feely, L. C.; Davis, S. S. Int J Pharm 1988, 41, 83.
13. Efentakis, M.; Al-Hmound, H.; Choulis, N. N. Acta Pharm Technol 1990, 36, 237.
14. Vlachou, M.; Hani, N.; Efentakis, M.; Tarantili, P. A.; Andreopoulos, A. G. J Biomater Appl 2000, 15, 65.
15. Nokhodchi, A.; Norouzi-Sani, S.; Siahi-Shadbad, M. R.; Lotfipoor, F.; Saeedi, M. Eur J Pharm Sci 2002, 54, 349.
16. Sako, K.; Sawada, T.; Nakashima, H.; Yokohama, S.; Sonobe, T. J Controlled Release 2002, 81, 165.
17. Gonza'lez, I. M.; Robles, L. V. Int J Pharm 2003, 251, 183.
18. Knan, G. M.; Zhu, J. B. J Controlled Release 1999, 57, 197.
19. Li, J. Z.; Rekhi, G. S.; Augsburger, L. L.; Shangraw, R. F. Pharm Dev Tech 1996, 1, 343.
20. Nazzal, S.; Nutan, M.; Palamakula, A.; Shah, R.; Zaghloul, A. A.; Khan, M. A. Int J Pharm 2002, 240, 103.
21. USP XXIII. United States Pharmacopeial Convention, Inc., Rockville, MD, 1995; p. 1328.
22. Ritger, P. L.; Peppas, N. S. J Controlled Release 1987, 5, 37.
23. United States Food and Drug Administration (FDA). Guidance for Industry, Dissolution Testing of Immediate Release Solid Oral Dosage Forms, Rockville, MD, August 1997; http://www. fda.gov/oder/guidance.htm.
24. Zuleger, S.; Lippold, B. C. Int J Pharm 2001, 217, 139.
25. Garzon, M. L.; Villafuerte, L. Int J Pharm 2002, 231, 33.